Advertisement
Regular Article| Volume 8, ISSUE 4, P201-217, June 1999

Download started.

Ok

Best practice guidelines for the management of women with epilepsy

Open ArchiveDOI:https://doi.org/10.1053/seiz.1999.0295
Best practice guidelines for the management of women with epilepsy
Next ArticleSerum prolactin levels after seizure and syncopal attacks
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Clinical guidelines for the treatment of epilepsy have been published . A statement on management issues for women with epilepsy has recently been produced by the American Academy of Neurology which has raised awareness of the issues facing women with epilepsy. The communication presented here aims to review current literature on specific issues relating to women with epilepsy, and proposes graded recommendations for its management within a UK health care framework.

      Keywords

      References

      References

        • Wallace H.
        • Shorvon S.D.
        • Hopkins A.
        • O’Donoghue M.
        Adults with Poorly Controlled Epilepsy. Royal College of Physicians, London1997
        • Scottish Intercollegiate Guidelines Network (SIGN)
        Diagnosis and Management of Epilepsy in Adults. Scotland, Scottish Intercollegiate Guidelines Network (SIGN). November 1997
        • Morrell M.
        Guidelines for the care of women with epilepsy.
        Neurology. 1998; 51 (Suppl. 4): S21-S27
        • Sackett D.L.
        • Rosenberg W.M.C.
        • Gray J.A.M.
        • Haynes R.B.
        • Richardson W.S.
        Evidence-based medicine: what it is and what it isn’t.
        British Medical Journal. 1996; 312: 71-72
        • Anon
        The periodic health examination. Canadian Task Force on the periodic health examination.
        Canadian Medical Association Journal. 1979; 121: 193-254
        • Appleton R.E.
        Epilepsy and the teenager.
        Current Paediatrics. 1996; 6: 88-91
        • Appleton R.E.
        • Chadwick D.
        • Sweeney A.
        Managing the teenager with epilepsy: paediatric to adult care.
        Seizure. 1997; 6: 27-30
        • Berkovic S.F.
        • Duncan J.S.
        • Barkovich A.
        ILAE neuroimaging commission recommendations for neuroimaging of patients with epilepsy.
        Epilepsia. 1997; 38: 1-2
        • Aicardi J.
        Epilepsy in Children. 2ndEdition. Raven Press, New York1994
        • Morrell M.J.
        Hormones and epilepsy through the lifetime.
        Epilepsia. 1992; 33 (Suppl. 4): S49-S61
        • Herzog A.G.
        Reproductive endocrine considerations and hormonal therapy for women with epilepsy.
        Epilepsia. 1991; 32 (Suppl. 6): S27-S33
        • Wallace H.
        • Shorvon S.
        • Tallis R.
        Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy.
        Lancet. 1998; 352: 1970-1973
        • Dansky L.V.
        • Andermann E.
        • Andermann F.
        Marriage and fertility in epileptic patients.
        Epilepsia. 1980; 21: 261-271
        • Webber M.P.
        • Hauser W.A.
        • Ottman R.
        • Annegers J.F.
        Fertility in persons with epilepsy: 1935–1974.
        Epilepsia. 1986; 27: 746-752
        • Schupf N.
        • Ottman R.
        Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences.
        Epilepsia. 1994; 35: 750-756
        • Herzog A.G.
        • Seibel M.M.
        • Schomer D.L.
        • Vaitukaitis J.L.
        • Geschwind N.
        Reproductive endocrine disorders in women with partial seizures of temporal lobe origin.
        Archives of Neurology. 1986; 43: 341-346
        • Isojärvi J.I.T.
        • Laatikainen T.J.
        • Knip M.
        • Pakarinen A.J.
        • Juntunen K.T.
        • Myllyla V.V.
        Obesity and endocrine disorders in women taking valproate for epilepsy.
        Annals of Neurology. 1996; 39: 579-584
        • Isojärvi J.I.T.
        • Laatikainen T.J.
        • Pakarinen A.J.
        • Juntunen K.T.
        • Myllyla V.V.
        Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
        New England Journal of Medicine. 1993; 329: 1383-1388
        • Isojärvi J.
        • Rättyä J.
        • Knip M.
        • Pakarinen A.
        • Myllal V.
        • Tapanainen J.
        Replacing valproate with lamotrigine reduces cardiovascular risks and insulin mediated hyperandrogenism in women with epilepsy.
        Epilepsia. 1997; 38 (Suppl. 3)
        • Bilo L.
        • Meo R.
        • Valentino R.
        • Buiscaino G.A.
        • Striano S.
        • Nappi C.
        Abnormal pattern of luteinising hormone pulsatility in women with epilepsy.
        Fertility and Sterility. 1991; 55: 705-711
        • Drislane F.W.
        • Coleman A.E.
        • Schomer D.L.
        • Ives J.
        • Levesque L.A.
        • Seibel M.M.
        • Herzog A.G.
        Altered pulsatility secretion of luteinising hormone in women with epilepsy.
        Neurology. 1994; 44: 306-310
        • Herzog A.G.
        Polycystic ovary syndrome in women with epilepsy: epileptic or iatrogenic.
        Annals of Neurology. 1996; 39: 559-560
        • Lobo R.A.
        A disorder without identity: ‘HCA’, ‘PCO’, ‘PCOD’, ‘PCOS’, ‘SLS’. What are we to call it.
        Fertility and Sterility. 1995; 63: 1158-1160
        • Betts T.
        • Crawford P.
        Women and Epilepsy. Martin Dunitz, London1998 (p. 27–28)
        • Herzog A.G.
        Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders.
        Neurology. 1986; 36: 1607-1610
        • Mattson R.H.
        • Cramer J.A.
        • Caldwell B.V.
        • Siconolfi B.C.
        Treatment of seizures with medroxyprogesterone acetate: preliminary report.
        Neurology (Cleveland). 1984; 34: 1255-1258
        • Duncan S.
        • Read C.L.
        • Brodie M.J.
        How common is catamenial epilepsy.
        Epilepsia. 1993; 34: 827-831
        • Mattson R.H.
        • Kamer J.A.
        • Caldwell B.V.V.
        • Cramer J.A.
        Seizure frequency and the menstrual cycle: a clinical study.
        Epilepsia. 1981; 22: 242
        • Herzog A.G.
        • Klein P.
        • Ransil B.J.
        Three patterns of catamenial epilepsy.
        Epilepsia. 1997; 38: 1082-1088
        • Mattson R.A.
        • Cramer J.A.
        Epilepsy, sex hormones and antiepileptic drugs.
        Epilepsia. 1985; 26 (Suppl. 1): S40-S51
        • Bäckstrom T.
        Symptoms related to the menopause and sex steroid treatments.
        Ciba Foundation Symposium. 1995; 191: 171-180
        • Laidlaw J.
        Catamenial epilepsy.
        Lancet. 1956; 271: 1235-1237
        • Bäckstrom T.
        Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle.
        Acta Neurologica Scandinavica. 1976; 54: 321-347
        • Rosciszewska D.
        • Buntner B.
        • Guz I.
        • Zawisza L.
        Ovarian hormones, anticonvulsant drugs and seizures during the menstrual cycle in women with epilepsy.
        Journal of Neurology, Neurosurgery and Psychiatry. 1986; 49: 47-51
        • Ansell B.
        • Clarke E.
        Acetazolamide in the treatment of epilepsy.
        British Medical Journal. 1956; 1: 650-654
        • Livingston S.
        Comprehensive Management of Epilepsy in Infancy, Childhood and Adolescence. Thomas Springfield, Illinois1972
        • Herzog A.G.
        Progesterone therapy in women with complex partial and secondary generalized seizures.
        Neurology. 1995; 45: 1660-1662
        • Dana-Haeri J.
        • Richens A.
        Effects of norethisterone on seizures associated with menstruation.
        Epilepsia. 1983; 24: 377-381
        • Feely M.
        • Gibson J.
        Intermittent clobazam for catamenial epilepsy: tolerance avoided.
        Journal of Neurology, Neurosurgery and Psychiatry. 1984; 47: 1279-1282
        • Feely M.
        • Calvert R.
        • Gibson J.
        Clobazam in catamenial epilepsy: a model for evaluating anticonvulsants.
        Lancet. 1982; 2: 71-73
        • Herzog A.G.
        Clomiphene therapy in epileptic women with menstrual disorders.
        Neurology. 1988; 38: 432-444
        • Coulam C.B.
        • Annegers J.F.
        Do anticonvulsants reduce the efficacy of oral contraceptives.
        Epilepsia. 1979; 20: 519-526
        • Koch S.
        • Losche G.
        • Jager-Roman E.
        • et al.
        Major birth malformations and antiepileptic drugs.
        Neurology. 1992; 42 (Suppl. 5): 83-88
        • Orme M.
        • Crawford P.
        • Chadwick D.
        • Back D.
        Contraception, epilepsy and pharmacokinetics.
        in: Trimble M.R. Women and Epilepsy. J. Wiley & Sons, Chichester1991: 145-158
        • Baruzzi A.
        • Albani R.
        • Riva R.
        Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
        Epilepsia. 1994; 35. (Suppl. 3): S14-S19
        • Trussell J.
        • Kost K.
        A guide to interpreting contraceptive efficacy studies.
        Obstetrics and Gynecology. 1990; 76: 558-567
        • Krauss G.L.
        • Brandt J.
        • Campbell M.
        • Plate C.
        • Summerfield M.
        Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians.
        Neurology. 1996; 46: 1534-1539
        • Morrell M.
        Sexuality in epilepsy.
        in: Engel J. Pedley T. A Comprehensive Textbook of Epilepsy. Lippincott-Raven, Philadelphia1997: 2021-2026
        • Betts T.
        • Kenwood C.
        Practical Psychiatry. Oxford University Press, Oxford1992 (p. 314–332)
        • Toone B.
        Epilepsy and sexual life.
        in: Hopkins A. Shorvon S. Cascino G. Epilepsy. 2ndEdition. Chapman-Hall, London1995: 557-564
        • Betts T.
        • Fox C.
        Evaluation of a preconception clinic for women with epilepsy.
        Seizure. 1999;
      52. British Medical Journal. 1993; 306: 1374-1378

      53. At a Glance Guide to the Current Medical Standards of Fitness to Drive

        • Gaily E.
        • Granstrom M.L.
        • Hiilesmaa V.
        • Bardy A.
        Minor abnormalities in children of mothers with epilepsy.
        Journal of Pediatrics. 1988; 112: 520-529
        • Annegers J.F.
        • Elveback L.R.
        • Hauser W.A.
        • Anderson V.E.
        • Kurland L.I.
        Congenital malformations and seizure disorders in the offspring of parents with epilepsy.
        International Journal of Epidemiology. 1978; 7: 241-247
        • Nakane Y.
        • Okuma T.
        • Takahishi R.
        • .
        • et al.
        Multi-institutional study on the teratogenicity and fetal toxicity of anticonvulsants: a report of a collaborative study group in Japan.
        Epilepsia. 1980; 21: 663-680
        • Dansky L.V.
        The teratogenic effects of epilepsy and anticonvulsant drugs.
        in: Hopkins A. Shorvon S. Cascino G. Epilepsy. 2ndEdition. Chapman and Hall, London1995: 535-536
        • Dencker L.
        Fetal development and sensitivity periods in man.
        in: Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd, Chichester1997: 1-9
        • Samren E.B.
        • van Duijn C.M.
        • Koch S.
        • et al.
        Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.
        Epilepsia. 1997; 38: 981-990
        • Gaily E.
        Minor abnormalities and effects on psychomotor development associated with maternal use of antiepileptic drugs.
        in: Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd, Chichester1997: 63-70
        • Lindhout D.
        • Hoppener R.J.E.A.
        • Meinardi H.
        Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation of carbamazepine.
        Epilepsia. 1984; 25: 77-83
        • Waters C.H.
        • Belai Y.
        • Gott P.S.
        • Shen P.
        • De Giorgio C.M.
        Outcomes of pregnancy associated with antiepileptic drugs.
        Archives of Neurology. 1994; 51: 250-253
        • Hanson J.W.
        • Smith D.W.
        The fetal hydantoin syndrome.
        Journal of Pediatrics. 1975; 87: 285-290
        • Lindhout D.
        • Omtzigt J.G.C.
        Teratogenic effects of antiepileptic drugs: Implication for the management of epilepsy in women of the child bearing age.
        Epilepsia. 1994; 35 (Suppl. 4): 19-28
        • Kallen B.
        • Robert E.
        • Mastroiacovo P.
        • Martinez-Frias M.L.
        • Castilla E.E.
        • Cocchi G.
        Anticonvulsant drugs and malformations: is there a drug specificity.
        European Journal of Epidemiology. 1989; 5: 31-36
        • Anderson R.C.
        Cardiac defects in children of mothers receiving anticonvulsant therapy during pregnancy.
        Journal of Pediatrics. 1976; 89: 318-319
        • Lindhout D.
        • Omtzigt J.G.C.
        • Cornel M.C.
        Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.
        Neurology. 1992; 42 (Suppl. 5): 111-118
        • Nau H.
        Toward the mechanism of valproic acid induced neural tube defects.
        in: Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Epilepsy and Pregnancy. Wrightson Biomedical Publishing, Chichester1997: 35-42
        • Rosa F.W.
        Spina bifida in infants of women treated with carbamazepine during pregnancy.
        New England Journal of Medicine. 1991; 324: 674-677
        • Jones K.L.
        • Lacro R.V.
        • Johnson K.A.
        • Adams J.
        Pattern of malformations in the children of women treated with carbamazepine during pregnancy.
        New England Journal of Medicine. 1989; 320: 1661-1666
        • Ornoy A.
        • Cohen E.
        Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.
        Archives of Disease in Childhood. 1996; 75: 517-520
        • Hanson J.W.
        • Buehler B.A.
        Fetal hydantoin syndrome: current status.
        Journal of Pediatrics. 1982; 101: 816-818
        • Nulman I.
        • Scolnik D.
        • Chitayat D.
        • Farkas L.D.
        • Koren G.
        Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications.
        American Journal of Medical Genetics. 1997; 68: 18-24
        • DiLiberti J.H.
        • Farndon P.A.
        • Dennis N.R.
        • Curry C.J.
        The fetal valproate syndrome.
        American Journal of Medical Genetics. 1984; 19: 473-481
        • Jager-Roman E.
        • Deichl A.
        • et al.
        Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid.
        Journal of Pediatrics. 1986; 108: 997-1004
        • Granstrom M.L.
        • Gaily E.
        Psychomotor development in children of mothers with epilepsy.
        Neurology. 1992; 42 (Suppl. 5): 144-148
        • Morrell M.
        The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy and fetal outcome.
        Epilepsia. 1996; 37 (Suppl. 6): S34
        • Petrere J.A.
        • Anderson J.A.
        Developmental toxicity studies in mice, rats and rabbits with anticonvulsant gabapentin.
        Fundamental Applied Toxicology. 1999; 23: 585-589
      79. Lancet. 1991; 338: 131-137
        • Czeizel A.E.
        • Dudas I.
        Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
        New England Journal of Medicine. 1992; 327: 1832-1835
        • Rosenberg I.H.
        Folic acid and neural-tube defects—time for action.
        New England Journal of Medicine. 1992; 327: 1875-1876
        • Berkovic S.F.
        • Howell R.A.
        • Hay D.A.
        • Hopper J.L.
        Epilepsies in twins: genetics of the major epilepsy syndromes.
        Annals of Neurology. 1998; 43: 435-445
        • Schmidt D.
        The effect of pregnancy on the natural history of epilepsy: a review of the literature.
        in: Janz D. Dam M. Richens A. Epilepsy, Pregnancy and the Child. Raven Press, New York1983: 3-14
        • Tomson T.
        Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Seizure control during pregnancy and delivery. Wrightson Biomedical Publishing, Chichester1997: 113-123
        • Tomson T.
        • Lindbom U.
        • Ekqvist B.
        • Sundqvist A.
        Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin.
        Epilepsia. 1994; 35: 122-130
        • Schmidt D.
        • Canger R.
        • Avanzini G.
        • et al.
        Change of seizure frequency in pregnant epileptic women.
        Journal of Neurology Neurosurgery and Psychiatry. 1983; 46: 751-755

      87. A. Bardy, 1982

        • Delgado-Escuera A.V.
        • Janz D.
        Consensus guidelines preconception counselling, management, and care of the pregnant woman with epilepsy.
        Neurology. 1992; 42 (Suppl. 5): 149-160
        • Yerby M.S.
        Contraception, pregnancy and lactation in women with epilepsy.
        Bailliere’s Clinical Neurology. 1996; 5: 887-908
        • Devinsky O.
        • Yerby M.S.
        Women with epilepsy: reproduction and effects of pregnancy on epilepsy.
        Neurologic Clinics. 1994; 12: 479-495
        • Steegers-Theunissen R.P.
        • Renier W.O.
        • Borm G.F.
        • et al.
        Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study.
        Epilepsy Research. 1994; 18: 261-269
        • Yerby M.S.
        Problems and management of the pregnant women with epilepsy.
        Epilepsia. 1997; 28 (Suppl. 3): 29-36
        • Beaussant-Defaye J.
        • Basten N.
        • Demarca C.
        • Beaussart M.
        Epilepsies and Reproduction. Grine, Lille1985
        • Lander C.M.
        • Eadie M.J.
        Plasma antiepileptic drug concentrations during pregnancy.
        Epilepsia. 1991; 32: 257-266
        • Yerby M.S.
        • Friel P.N.
        • McCormack K.
        Antiepileptic drug disposition during pregnancy.
        Neurology. 1992; 42 (Suppl. 5): 12-16
        • Hyett J.
        • Perdu M.
        • Sharland G.
        • Snijders R.
        • Nicolaides K.
        Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks gestation: population based cohort study.
        British Medical Journal. 1999; 318: 81-85
        • Patsalos P.N.
        • Duncan J.S.
        Antiepileptic drugs. A review of clinically significant drug interactions.
        Drug Safety. 1993; 9: 156-186
        • Anon
        ACOG Educational Bulletin. Seizure disorders in pregnancy. Number 231, Dec 1996. Committee on Education. Bulletins of the American College of Obstetricians and Gynecologists.
        International Journal of Gynaecology and Obstetrics,1997 (p. 279–286)
        • Sabers A.
        Complications during pregnancy and delivery.
        in: Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd, Chichester1997: 105-111
        • Lulseged S.
        Haemorrhagic disease of the newborn: a review of 127 cases.
        Annals of Tropical Paediatrics. 1993; 13: 331-336
        • Clarkson P.
        • James A.
        Parenteral vitamin K: the effective prophylaxis against haemorrhagic disease for all newborn infants.
        New Zealand Medical Journal. 1990; 103: 95-96
        • Huysman M.W.
        • Sauer P.J.
        The vitamin K controversy.
        Current Opinion in Pediatrics. 1994; 6: 129-134
        • VonKries R.
        Neonatal vitamin K prophylaxis: the Gordian Knot still awaits untying.
        British Medical Journal. 1998; 316: 161-162
        • Ekelund H.
        • Finnstrom O.
        • Gunnarskog J.
        • Kallen B.
        • Larsson Y.
        Administration of vitamin K to newborn infants and childhood cancer.
        British Medical Journal. 1993; 307: 89-91
        • Anon
        Which vitamin K preparation for the newborn.
        Drug and Therapeutic Bulletin. 1998; 36: 17-19
        • Parker L.
        • Cole M.
        • Craft A.W.
        • Hey E.N.
        Neonatal vitamin K administration and childhood cancer in the North of England.
        British Medical Journal. 1998; 316: 189-193
        • McKinney P.A.
        • Juszczak E.
        • Findlay E.
        • Smith K.
        Case-control study of childhood leukaemia and cancer in Scotland: findings for neonatal intramuscular vitamin K.
        British Medical Journal. 1998; 316: 173-177
        • Passmore S.J.
        • Draper G.
        • Brownbill P.
        • Kroll M.
        Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer.
        British Medical Journal. 1998; 316: 184-189
        • Passmore S.J.
        • Draper G.
        • Brownbill P.
        • Kroll M.
        Case-control studies of relation between childhood cancer and neonatal vitamin K administration.
        British Medical Journal. 1998; 316: 178-184
        • Hopkins A.
        • Shorvon S.
        Definitions and epidemiology of epilepsy.
        in: Hopkins A. Shorvon S. Cascino F. Epilepsy. 2ndEdition. Chapman Hall, London1995: 1-24
        • Chien P.F.
        • Khan K.S.
        • Arnott N.
        Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: an overview of the evidence from randomized trials.
        British Journal of Obstetrics and Gynaecology. 1996; 103: 1985-1991
        • Lewis R.
        • Sibai B.
        Recent advances in the management of pre-eclampsia.
        Journal of Maternal and Fetal Medicine. 1997; 6: 6-15
        • Witlin A.G.
        • Friedman S.A.
        • Sibai B.M.
        The effect of magnesium sulfate therapy on the duration of labor in women with pre-eclampsia at term: a randomized, double-blind, placebo-controlled trial.
        American Journal of Obstetrics and Gynecology. 1997; 176: 623-627
        • Nau H.
        • Kuhnz W.
        • Egger H.J.
        • Rating I.
        • Helge H.
        Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics.
        Clinical Pharmacokinetics. 1982; 7: 508-543
        • Matheson I.
        • Skjaeraasen J.
        Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between breast differences in two patients.
        European Journal of Pharmacology. 1988; 35: 217-220
        • Fleishaker J.C.
        • Desai N.
        • McNamara P.J.
        Factors affecting the milk to plasma drug concentration ratio in lactating women: physical interactions with protein and fat.
        Journal of Pharmacological Science. 1987; 76: 189-193
        • Tomson T.
        • Ohman I.
        • Vitols S.
        Lamotrigine in pregnancy and lactation: a case report.
        Epilepsia. 1997; 38: 1039-1041
        • Rambeck B.
        • Kurlemann G.
        • Stodieck S.R.
        • May T.W
        • Jurgens U.
        Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child.
        European Journal of Clinical Pharmacology. 1997; 51: 481-484
        • Ohman I.
        • Tomson T.
        • Vitols S.
        Lamotrigine levels in plasma and breast milk in nursing women and their infants.
        Epilepsia. 1998; 39 (Suppl. 2): 21
        • Briggs G.G.
        • Freeman R.K.
        • Yaffe S.J.
        Drugs in Pregnancy and Lactation. 4thEdition. Williams and Wilkins, Baltimore1994
        • Bennet P.N.
        • the WHO Working Group
        Drugs and Human Lactation. Elsevier, Amsterdam1988
        • Vinge E.
        Breast feeding and antiepileptic drugs.
        in: Tomson T. Gram L. Sillanpaa M. Johannessen I.S. Epilepsy and Pregnancy. Wrightson Biomedical Publishing Ltd, Chichester1997: 93-103
        • Vermeulen J.
        • Aldenkamp A.P.
        Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research.
        Epilepsy Research. 1995; 22: 65-95
        • Meador K.J.
        Cognitive side-effects of antiepileptic drugs.
        Canadian Journal of Neurological Science. 1994; 21: S12-S16
        • Rosciszewska D.
        Epilepsy and the menstrual cycle.
        Pol Tyg Lek. 1994; 49: 99-101
        • Khaw K.T.
        Hormone replacement therapy again.
        British Medical Journal. 1998; 316: 1842-1844
        • Crawford P.
        • Lee P.
        Gender difference in the management of epilepsy—what women are hearing.
        Seizure. 1999; 8: 135-139
        • Grodstein F.
        • Stampfer M.J.
        • Manson J.E.
        • et al.
        Postmenopausal oestrogen and progestin use and the risk of cardiovascular disease.
        New England Journal of Medicine. 1996; 335: 453-461
        • Department of Health and Social Security
        Report of the Working Group on Services for People with Epilepsy. HMSO, London1986
        • Taylor M.P.
        Epilepsy in a Doncaster practice: audit and change over eight years.
        Journal of the Royal College of General Practitioners. 1987; 37: 116-119
        • Brown S.
        • Betts T.
        • Crawford P.
        • Hall B.
        • Shorvon S.
        • Wallace S.
        Epilepsy needs revisited: a revised epilepsy needs document for the UK.
        Seizure. 1998; 7: 435-440
        • Crawford P.
        Guide to the withdrawal of antiepileptic drugs.
        Prescriber. 1998; 9: 113-115
        • Taylor M.
        • Readman S.
        • Hague B.
        • Boulter V.
        • Hughes L.
        • Howell S.
        A district epilepsy service, with community-based specialist liaison nurses and guidelines for shared care.
        Seizure. 1994; 3: 121-127
        • Ridsdale L.
        Diagnosis and care of epilepsy.
        Practitioner. 1997; 241: 528-533
        • Taylor M.P.
        Managing Epilepsy in Primary Care. Blackwell Science, Oxford1996
        • Hall B.
        • Martin E.
        • Smithson H.
        Epilepsy: A General Practice Problem. Royal College of General Practitioners, London1997

      Article info

      Identification

      DOI: https://doi.org/10.1053/seiz.1999.0295

      Copyright

      © 1999 BEA Trading, Ltd. Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX